Yoshida Yilin, Schmaltz Chester L, Jackson-Thompson Jeanette, Simoes Eduardo J
Yilin Yoshida, PhD, MPH is in the University of Missouri School of Medicine, Department of Health Management and Informatics, and the Missouri Cancer Registry and Research Center.
Chester L. Schmaltz, PhD is in the University of Missouri School of Medicine, Department of Health Management and Informatics, and the Missouri Cancer Registry and Research Center.
Mo Med. 2018 Nov-Dec;115(6):542-547.
We evaluated relative survival (RS) for ovarian cancer (OC) overall, by demographic and by clinicopathological characteristics in Missouri. Survival data from the Missouri Cancer Registry were obtained for cases diagnosed 1996-2014. An improved OC survival, especially in late stage, was observed in the study period. Our findings showed demographic, especially race-associated, and geographical variations of OC survival. OC survival also differed by first course treatment received and histology. These differences indicate disparities in OC care.
我们评估了密苏里州卵巢癌（OC）的总体相对生存率（RS），并按人口统计学特征和临床病理特征进行了评估。从密苏里癌症登记处获取了1996年至2014年确诊病例的生存数据。在研究期间观察到卵巢癌生存率有所提高，尤其是晚期。我们的研究结果显示了卵巢癌生存率在人口统计学方面的差异，尤其是与种族相关的差异以及地理差异。卵巢癌生存率还因接受的初始治疗和组织学类型而异。这些差异表明卵巢癌治疗存在差异。
